Paid Clinical Trials in Hartford, CT
As of August 2026, 234 paid clinical trials are recruiting in Hartford, Connecticut. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Hartford offers studies at sites including Hartford Hospital for conditions such as Neuroblastoma, Degenerative Disc Disease, Breast Cancer, Heart Failure. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Hartford
Trials by drug in Hartford
Filter results
211 clinical trials
A Study of Brenipatide in Adult Participants With Schizophrenia
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Assessment of CCM in HF With Higher Ejection Fraction
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
ELEVATE-HFpEF Clinical Study
A Study to Assess Growth in Children With Idiopathic Short Stature
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Strategy for Improving Stroke Treatment Response
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
FORWARD CAD IDE Study
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
PARTNER 3 Trial - Aortic Valve-in-Valve
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Top Research Study Locations in Hartford
Researchers run research studies in Hartford, CT at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Hartford Hospital | Atrial Fibrillation, Coronary Artery Disease, Heart Failure | 61 |
| Connecticut Children's Medical Center | Sickle Cell Disease, B Acute Lymphoblastic Leukemia, Crohn's Disease | 58 |
| Smilow Cancer Hospital Care Center at Saint Francis | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma | 33 |
| Hartford Healthcare | Opioid Use, Pancreatic Cancer, Advanced Solid Tumor | 16 |
| Connecticut Children's Hospital | Neuroblastoma, Ewing Sarcoma, Osteosarcoma | 7 |
| Connecticut Children's | Glycogen Storage Disease Type I, Glycogen Storage Disease Type IA, Glycogen Storage Disease Type IB | 4 |
| Hartford Healthcare Alliance (Data Collection Only) | Advanced Melanoma, Gastrointestinal Cancer, Glioma | 4 |
| Hartford Healthcare Bone and Joint Institute | Degenerative Disc Disease, Cervical Spinal Instability, Degenerative Scoliosis | 3 |
| Hartford Healthcare Cancer Institute @ Hartford Hospital | Acute Leukemia, Endometrial Cancer, Endometrial Cancer Stage I | 3 |
| Smilow Cancer Hospital at Saint Francis | Breast Cancer, HER2-positive Metastatic Breast Cancer, Metastatic Breast Cancer | 3 |
| Institute of Living | Major Depressive Disorder, Schizophrenia | 2 |
| Connecticut Children's Medical Center - Hartford | Duchenne Muscular Dystrophy, Crohn's Disease | 2 |
| Hartford HealthCare Cancer Institute | Acute Myeloid Leukemia (AML), Chemotherapy-induced Peripheral Neuropathy, Gynecologic Cancer | 2 |
| Anxiety Disorders Center, Institute of Living | Hoarding Disorder | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Clinical Trial Site | Hypophosphatasia | 1 |
| Connecticut Army National Guard | Suicide | 1 |
| Hartford Health Care | Atrial Fibrillation (AF), VTE | 1 |
| Hartford Health Hospital | Stroke, Stroke, Acute, Stroke, Ischemic | 1 |
| Hartford HealthCare - Hartford Hospital | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer | 1 |
| Hartford HealthCare Cancer Institute at Hartford Hospital | Metastatic Castration-resistant Prostate Cancer | 1 |
| Hartford HealthCare The Bone and Joint Institute | Knee Cap, Knee Cap Injury, Knee Deformity | 1 |
| Hartford Healthcare (Data Collection Only) | HPV-Related Squamous Cell Carcinoma | 1 |
| Hartford Healthcare (Data Collection) | Clinical Stage: Stage II (T3-4, N-), Rectal Adenocarcinoma, Solid Tumor | 1 |
| Hartford Healthcare Bone & Joint Institute | Cervical Disc Disease, Cervical Fusion, Cervical Instabilities Spine | 1 |
Active & Upcoming Studies in Hartford (2026)
Recruiting trials in Hartford grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (93 active studies)
- Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas · Phase 1, Phase 2 · Milton S. Hershey Medical Center
- Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · Natera, Inc.
Cardiovascular (19 active studies)
- A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation · Biosense Webster, Inc.
- Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest · Phase 3 · Invero Pharma, Inc.
Neurology & pain (12 active studies)
- Interoceptive Awareness and Function in Adolescents With Chronic Pain · Connecticut Children's Medical Center
- MMA Embolization for Refractory Chronic Migraine · Cerenovus, Part of DePuy Synthes Products, Inc.
Pediatric (7 active studies)
- Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease · Connecticut Children's Medical Center
- Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs · Kimberley Roche
Mental health & behavior (5 active studies)
- A Study of Brenipatide in Adult Participants With Schizophrenia · Phase 2 · Eli Lilly and Company
- Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs · Kimberley Roche
Diabetes & metabolic (5 active studies)
- A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · University of Connecticut
- Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy · Hartford HealthCare
Vaccines (1 active study)
Common conditions studied in Hartford
- Neuroblastoma (8 active studies)
- Degenerative Disc Disease (6 active studies)
- Breast Cancer (5 active studies)
- Heart Failure (5 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Coronary Artery Disease (4 active studies)
Leading research sponsors in Hartford
- National Cancer Institute (NCI)
- Children's Oncology Group
- Connecticut Children's Medical Center
- SWOG Cancer Research Network
- Memorial Sloan Kettering Cancer Center
Frequently asked questions
How many paid clinical trials are currently recruiting in Hartford?
There are approximately 234 recruiting clinical trials in Hartford, Connecticut listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Hartford pay participants?
Most recruiting trials in Hartford compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Hartford?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Hartford?
The most common conditions under active study in Hartford include Neuroblastoma (8), Degenerative Disc Disease (6), Breast Cancer (5), Heart Failure (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Hartford?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Hartford on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Hartford?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Hartford?
Recruiting research sites in Hartford include Hartford Hospital, Connecticut Children's Medical Center, Smilow Cancer Hospital Care Center at Saint Francis, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Hartford right now?
The largest active categories in Hartford are Cancer & tumors (93), Cardiovascular (19), Neurology & pain (12). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.